GNN - Genome News Network  
  Home | About | Topics
   
Introduction | Overview
2004 Rat
2002 Mouse
2001 30,000 Genes
2000 The Human Genome
1999 Fruit Fly
1998 Worm
1996 An Extremophile
1996 Yeast
1995 Haemophilus
1991 Venter
1986 Human Genome
1986 Hood
1983 Mullis
1978 Botstein
1977 Gilbert & Sanger
1973 Boyer & Cohen
1972 Berg
1970 Smith
1970 Temin & Baltimore
1969 Beckwith
1967 Weiss & Green
1961 Jacob & Monod
1961 Nirenberg
1960 mRNA
1957 Crick
1956 Kornberg
1953 Crick & Watson
1950 Chargaff
1944 Avery
1943 Delbruck & Luria
1941 Beadle & Tatum
1934 Bernal
1927 Muller
1913 Sturtevant
1910 Morgan
1909 Johannsen
1908 Garrod
1904 Bateson
1902 Boveri & Sutton
1900 Rediscover Mendel
1888 Boveri
1882 Flemming
1876 Galton
1869 Miescher
1866 Mendel
1859 Darwin


 Printer Friendly
Genetics and Genomics Timeline
1973
Herbert Boyer (1936-) and Stanley N. Cohen (1935-) develop recombinant DNA technology, showing that genetically engineered DNA molecules may be cloned in foreign cells

Genetic engineering using living organisms was first accomplished soon after it became feasible in the early 1970s. In 1973 Herbert Boyer, of the University of California at San Francisco, and Stanley Cohen, at Stanford University, reported the construction of functional organisms that combined and replicated genetic information from different species. Their experiments dramatically demonstrated the potential impact of DNA recombinant engineering on medicine and pharmacology, industry and agriculture.


Herbert Boyer
Boyer and Cohen's achievement represented an advance upon the ingenious techniques developed by Paul Berg, in 1972, for inserting viral DNA into bacterial DNA. It was a creative synthesis of earlier research that made use of:

• Living organisms able to serve as carriers for genes from another organism.

• Enzymes to cleave and rejoin DNA fragments that contain such genes.

• DNA molecules from one organism precisely targeted and manipulated for insertion into the DNA of another organism.

Boyer and Cohen, both biochemists, recognized the complementary nature of their work in 1972. Cohen's research involved plasmids—the nonchromosomal, circular units of DNA found in, and sometimes exchanged by, bacteria. Boyer was working on restriction enzymes, produced by bacteria to counter invasion by viral organisms known as bacteriophages. In general, restriction enzymes and plasmids are both part of natural systems of defense evolved by bacteria; both, when Boyer and Cohen began to work together, were recent discoveries.


Stanley N. Cohen

In 1970 Cohen found a way in which E. coli could be made to acquire a plasmid, known as pSC101, that conferred resistance to the antibiotic tetracycline. Together, Boyer and Cohen discovered that an enzyme, Eco RI, would cleave the circular plasmid at a single site. Into the breach they inserted a gene that provided resistance to another antibiotic, kanamycin. They then repaired the plasmid. Subsequent colonies of E. coli included bacteria that were resistant both to tetracycline and to kanamycin.

Boyer and Cohen repeated the basic recombination in other ways, using a plasmid from another species of bacteria, for example. But most significantly, they also introduced genes from the toad Xenopus laevis into bacteria, demonstrating that these genes were active in generation after generation of E. coli. Bacteria, which replicate every twenty minutes, could in principle be employed on a large scale to manufacture the products of genes from higher animals, which reproduce much less frequently. Genes and gene products could be produced rapidly and in quantity.

The demonstration of recombinant DNA represented a watershed in a long series of advances in molecular genetics and biochemistry. Within several years, enhanced by new techniques for mapping and rapidly sequencing genes, genetic engineering became the basis for an explosion in biotechnology that continues unabated to the present.

Herbert Boyer and Stanley N. Cohen both winners of the
1980 Albert Lasker Award for Basic Medical Research


Back to GNN Home Page